Work

Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma

Year: 2024

Type: article

Abstract: Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Source: Molecular Therapy Oncology

DOI: 10.1016/j.omton.2024.200894

Authors: Wen Luo, Aliza Gardenswartz, Hai Hoang, Yaya Chu, Meijuan Tian, Yanling Liao, Janet Ayello, Jeremy M. Rosenblum, Xiaokui Mo, A. Mario Marcondes, Willem W. Overwijk, Timothy P. Cripe, Dean A. Lee, Mitchell S. Cairo

Institutions: New York Medical College, The Ohio State University, Nektar Therapeutics (United States), Nationwide Children's Hospital, Abigail Wexner Research Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900

Funders: Pediatric Cancer Research Foundation, Children's Cancer and Blood Foundation, University of Pennsylvania, University of California, San Francisco, National Cancer Institute, Moonshot Research and Development Program, Cancer Moonshot

Award: G1442899210

OpenAlex ID: W4403527754

FWCI: 0.311

Cites: 34

Cited by: 2

Related to: 10